GH Research plc (GHRS) | Financial Analysis & Statements
GH Research plc Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
0
Operating Income
-16.7M
Net Income
-14.1M
Balance Sheet Metrics
Total Assets
288.2M
Total Liabilities
8.5M
Shareholders Equity
279.7M
Debt to Equity
0.03
Cash Flow Metrics
Operating Cash Flow
-13.8M
Free Cash Flow
-12.3M
Revenue & Profitability Trend
GH Research plc Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses | |||||
| Research & Development | 38.8M | 35.0M | 29.8M | 20.5M | 8.6M |
| Selling, General & Administrative | 21.7M | 15.0M | 11.1M | 10.1M | 6.5M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 60.4M | 50.0M | 40.9M | 30.5M | 15.1M |
| Operating Income | -60.7M | -50.2M | -41.2M | -30.7M | -15.1M |
| Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Non-Operating Items | |||||
| Interest Income | 5.1M | 6.3M | 6.0M | 858.0K | 0 |
| Interest Expense | 35.0K | 48.0K | 63.0K | 0 | 9.0K |
| Other Non-Operating Income | 7.8M | 5.7M | 329.0K | 7.5M | 5.9M |
| Pre-tax Income | -48.3M | -39.0M | -35.6M | -22.5M | -9.2M |
| Income Tax | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -48.3M | -39.0M | -35.6M | -22.5M | -9.2M |
| Net Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Key Metrics | |||||
| EBITDA | -55.7M | -44.3M | -35.5M | -29.9M | -15.1M |
| EPS (Basic) | $-0.79 | $-0.75 | $-0.68 | $-0.43 | $-0.21 |
| EPS (Diluted) | $-0.79 | $-0.75 | $-0.68 | $-0.43 | $-0.21 |
| Basic Shares Outstanding | 61042621 | 51948000 | 52333824 | 52020849 | 43683296 |
| Diluted Shares Outstanding | 61042621 | 51948000 | 52333824 | 52020849 | 43683296 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
GH Research plc Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 246.3M | 100.8M | 78.4M | 166.0M | 276.8M |
| Short-term Investments | 34.5M | 48.5M | 83.1M | 0 | - |
| Accounts Receivable | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other Current Assets | - | 1.6M | 119.0K | 47.0K | 10.0K |
| Total Current Assets | 286.0M | 154.2M | 164.1M | 168.5M | 279.8M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 1.7M | 1.1M | 1.2M | 10.0K | 29.0K |
| Goodwill | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 1.6M | - | - | - | - |
| Total Non-Current Assets | 2.3M | 34.0M | 62.2M | 85.8M | 82.0K |
| Total Assets | 288.2M | 188.3M | 226.3M | 254.4M | 279.9M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 3.8M | 3.7M | 3.5M | 1.9M | 883.0K |
| Short-term Debt | 365.0K | 255.0K | 343.0K | - | - |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 407.0K | 704.0K | 203.0K | 95.0K | 72.0K |
| Total Current Liabilities | 8.4M | 9.0M | 6.7M | 4.5M | 2.7M |
| Non-Current Liabilities | |||||
| Long-term Debt | 147.0K | 369.0K | 631.0K | 0 | - |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | 147.0K | 369.0K | 631.0K | 0 | 0 |
| Total Liabilities | 8.5M | 9.3M | 7.3M | 4.5M | 2.7M |
| Equity | |||||
| Common Stock | 1.6M | 1.3M | 1.3M | 1.3M | 1.3M |
| Retained Earnings | -154.4M | -106.4M | -67.9M | -32.5M | -10.0M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 279.7M | 179.0M | 219.0M | 249.8M | 277.2M |
| Key Metrics | |||||
| Total Debt | 512.0K | 624.0K | 974.0K | 0 | 0 |
| Working Capital | 277.6M | 145.3M | 157.4M | 164.0M | 277.1M |
Balance Sheet Composition
GH Research plc Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -48.3M | -39.0M | -35.6M | -22.5M | -9.2M |
| Depreciation & Amortization | 335.0K | 315.0K | 315.0K | 47.0K | 19.0K |
| Stock-Based Compensation | 8.5M | 1.2M | 2.3M | 1.7M | 366.0K |
| Working Capital Changes | 0 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | -50.1M | -46.6M | -41.2M | -21.8M | -8.8M |
| Investing Activities | |||||
| Capital Expenditures | -121.0K | -49.0K | -100.0K | -67.0K | -104.0K |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | 0 | 0 | -54.0M | -84.6M | 0 |
| Investment Sales | 46.3M | 65.2M | - | - | - |
| Investing Cash Flow | 46.2M | 65.1M | -54.1M | -84.7M | -104.0K |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | -197.0K | -304.0K | -219.0K | 0 | 0 |
| Financing Cash Flow | 139.7M | -304.0K | -204.0K | 0 | 286.4M |
| Free Cash Flow | -43.7M | -42.3M | -33.4M | -26.3M | -15.4M |
| Net Change in Cash | 135.7M | 18.2M | -95.5M | -106.5M | 277.5M |
Cash Flow Trend
GH Research plc Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-23.81
Forward P/E
-10.32
Price to Book
4.20
PEG Ratio
-10.32
Profitability Ratios
Profit Margin
0.00%
Operating Margin
0.00%
Return on Equity
-21.04%
Return on Assets
-15.92%
Financial Health
Current Ratio
34.13
Debt to Equity
0.18
Beta
1.00
Per Share Data
EPS (TTM)
$-0.79
Book Value per Share
$4.51
Revenue per Share
$0.00
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| GHRS | 1.2B | -23.81 | 4.20 | -21.04% | 0.00% | 0.18 |
| Vertex | 109.4B | 28.40 | 5.92 | 22.54% | 32.94% | 10.91 |
| Regeneron | 81.0B | 18.00 | 2.45 | 14.86% | 31.41% | 9.51 |
| Recursion | 1.9B | -2.44 | 1.64 | -59.54% | 4.45% | 6.89 |
| Capricor | 2.0B | -15.61 | 6.62 | -46.56% | 0.00% | 4.75 |
| Zymeworks | 2.0B | 3.79 | 7.32 | -26.72% | -76.56% | 6.80 |
Financial data is updated regularly. All figures are in the company's reporting currency.






